Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study.

Giuseppina AffinitoUgo TramaLaura PalumboMaria Grazia FumoRoberta GiordanaMassimo Di GennaroMaria TriassiRoberta LanzilloVincenzo Brescia MorraRaffaele PalladinoMarcello Moccia

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

DMT prescriptions quickly returned to pre-pandemic levels, reflecting good health system recovery. However, adherence has remained lower than the past, as from suboptimal care. Assessing long-term COVID-19 impact on MS healthcare is warranted.

Keyphrases

healthcare
coronavirus disease
sars cov
multiple sclerosis
respiratory syndrome coronavirus
mass spectrometry
ms ms
white matter
palliative care
health information
quality improvement
metabolic syndrome
skeletal muscle
chronic pain
adipose tissue
health insurance